BiotechTube
Home/Galmed Pharmaceuticals/Guy Nehemya, Adv.
GN

Guy Nehemya, Adv.

Chief Operating Officer

Galmed Pharmaceuticals

Therapeutic Areas

Liver Diseases (NASH/Fibrosis)Inflammatory Diseases

Galmed Pharmaceuticals Pipeline

DrugIndicationPhase
Aramchol MeglumineNASH and FibrosisPhase 3
Amilo-5MERInflammatory DiseasesPreclinical

Leadership Team at Galmed Pharmaceuticals

AB
Allen Baharaff
Chief Executive Officer & President
DC
Doron Cohen
Chief Financial Officer
LH
Liat Hayardeny - Brueck, Ph.D.
Chief Scientific Officer
YS
Yohai Stenzler, CPA
Chief Accounting Officer
YG
Yossi Gilgun-Sherki, Ph.D.
Executive Clinical Consultant
TG
Tali Gorfine, M.D.
Executive Clinical Development Consultant
JP
John Posner
Clinical Pharmacology Specialist
SE
Shaul E. Kadosh
Biostatistical & Clinical Research Consultant
JK
Joseph Kaspi, Ph.D.
Senior CMC Director (Consultant)
DM
Dalia Medini, Ph.D.
Analytical Advisor (Consultant)
View full Galmed Pharmaceuticals profile